Forecast of Global Hyperimmune Globulins Consumption Market 2023

Global Hyperimmune Globulins market will register a 9.7% CAGR in terms of revenue, reach US$ 1960 million by 2023, from US$ 1120 million in 2017. Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc.